Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
NPS PHARMACEUTICALS INC
| Metric | NPS PHARMACEUTICALS INC Healthcare |
|---|---|
| Quality Score | 48 / 100 |
| Revenue (latest) | $44M |
| Net income (latest) | −$9M |
| Operating margin | −6.7% |
| Net margin | −19.8% |
| Return on equity | −6.5% |
| Return on assets | −3.0% |
| Return on capital (ROCE) | −1.3% |
| Debt / equity | 1.16× |
| Revenue growth (YoY) | 73.2% |
| Altman Z″ (distress) | -6.23 |
| Accruals / assets | 2.8% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.